Reading IONS? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track IONS free→Reading IONS? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track IONS free→QuarterlyIQ Insights · IONS
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (d) Appointment of Ludwig N. Hantson to the Board of Directors On June 4, 2026, the Board of Directors (“ Board ”) of Ionis Pharmaceuticals, Inc. (the “ Company ”) appointed Ludwig N. Hantson as a member of the Company’s Board effective June 4, 2026, immediately following the Company’s 2026 Annual Meeting of Stockholders. Dr. Hantson has more than…
Importance-ranked changes since the prior daily snapshot.
Valuation label changed from 'expensive' to 'full'.
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.